In vitro Services | Charles River Discovery Services

Bioanalysis 

The speed of lead candidate selection studies requires an equally rapid analytical tool to efficiently measure drug concentrations in the biological samples collected. Charles River offers non-GLP discovery bioanalytical services either in support of studies conducted in-house or as a stand-alone service with the flexibility and speed to meet the timelines and diverse needs for discovering the best drug candidate.

Our research-grade assay approach via LC-MS/MS can quickly analyze samples for compound ranking. Once a lead candidate has been selected in the discovery analytical process, these methods can be transferred to method development for GLP bioanalytical testing including feasibility, validation and preclinical and clinical sample analysis.

For more information about our discovery bioanalysis services, please contact us at askcharlesriver@crl.com.


Related Information

Discovery, Preclinical & Clinical Bioanalysis Datasheet
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jun 13 - Neurological Biomarkers in Efficac...
Jun 06 - GLP-Compliant ELISpot and FluoroSp...
Jun 24-Jun 26 - London, UK - Skin Forum 2013
Jun 21-Jun 25 - Chicago, IL - American Diabetes Association’s 73rd Scientific Sessions
Sep 09-Sep 11 - Carlsbad, CA - 19th Annual Biotechnology-Derived Therapeutics Perspecti...
Jun 28-Jun 28 - Frankfurt, Germany - Seminar: Health Monitoring of Laboratory Animals

Charles River Laboratories, Inc.